Linsidomine
 | |
| Clinical data | |
|---|---|
| Other names | SIN-1 |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
JSmol) | |
| |
| |
| (verify) | |
Linsidomine (3-morpholinosydnonimine or SIN-1vasodilator. It is a metabolite of the antianginal drug molsidomine and acts by releasing NO from the endothelial cells nonenzymatically. It also hyperpolarizes the cell membrane through influencing the sodium-potassium pump and thereby rendering it less responsive to adrenergic stimulation. Linsidomine injection at a dose of 1 mg produces usable erection[2] in about 70% of patients and full erection in up to 50% of patients. Linsidomine does not appear to be associated with priapism.[citation needed]
Linsidomine is neurotoxic and promotes
neurodegenerative diseases.[4]